Kames Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$115M Buy
2,119,945
+336,845
+19% +$18.8M 3.39% 5
2014
Q3
$101M Sell
1,783,100
-2,428
-0.1% -$136K 3.15% 5
2014
Q2
$98.5M Buy
1,785,528
+38,353
+2% +$2.09M 3.14% 5
2014
Q1
$94.7M Buy
1,747,175
+54,422
+3% +$2.82M 2.99% 5
2013
Q4
$80.9M Sell
1,692,753
-172,541
-9% -$7.89M 2.69% 8
2013
Q3
$84.7M Sell
1,865,294
-146,024
-7% -$6.67M 2.61% 9
2013
Q2
$89.1M Buy
+2,011,318
New +$89.8M 3.14% 6

Other funds holding MRK

Kames Capital Management's MRK Position: Q4 2014 in Review

Kames Capital Management increased its Merck (MRK) stake by 19% in Q4 2014, buying an estimated $18.8M and bringing the position to 2,119,945 shares worth $115M. The position accounts for 3.39% of the portfolio, ranked #5.

Kames Capital Management first reported a position in MRK in Q2 2013 and has held it in 7 quarters since. 1,721 funds tracked by Wall St. Rank hold MRK as of Q4 2014.

  • Kames Capital Management held 2,119,945 shares of Merck worth $115M as of Q4 2014.
  • Kames Capital Management bought 336,845 Merck shares in Q4 2014, an estimated $18.8M.
  • Merck made up 3.39% of Kames Capital Management's portfolio in Q4 2014, its #5 holding.
  • Kames Capital Management first reported a position in Merck in Q2 2013 and has held it in 7 quarters since.
  • 1,721 funds tracked by Wall St. Rank held Merck as of Q4 2014.

Based on Kames Capital Management's 13F filing for Q4 2014, filed 3 Feb 2015.